First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid Tumors

Clinical trial NCT01014936 · COMPLETED

Trial details

NCT number: NCT01014936
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available

Start date: 2009-11-30
Primary completion: 2015-10-31
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.